|
RNAC Cartesian Therapeutics Inc 1453687 |
| Balance Sheet |
|
Current Assets
|
229,136,000 |
|
Assets
|
455,316,000 |
|
Current Liabilities
|
21,405,000 |
|
Liabilities
|
454,564,000 |
|
Equity
|
752,000 |
|
Shares Out
|
26,509,000 |
| Cash Flow Statement |
|
Operating Cash Flow
|
-16,672,000 |
|
Investing Cash Flow
|
-8,388,000 |
| Market Analysis |
Market Cap
|
182,647,213 |
|
Price
|
6.89 |
|
BVPS
|
0.04 |
|
PB
|
434.66 |
|
EPS
|
-5.02 |
|
PS
|
43520.92 |
|
FCF
|
-25,060,000 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RNAC documents filed with the SEC.
RNAC Filings
Clear
